Skip to main content

Advertisement

Log in

Suppression of proinflammatory cytokine production in macrophages by lansoprazole

  • Original Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

Macrophages (MPs) produce increased levels of proinflammatory cytokines in Crohn’s disease; these cytokines are thought to play a central role in the occurrence of the disease. Biologics are currently available for anti-cytokine therapy, but treating intestinal inflammation through direct suppression of proinflammatory cytokine production could be more effective. P-ATPase inhibitors have been reported to be anti-inflammatory, and these inhibitors might suppress the production of MP proinflammatory cytokines. In this study, we examined the effect of two types of ATPase inhibitors on the expression patterns of typical proinflammatory cytokines. Peritoneal MPs from 6- to 8-week-old mice were cultured for 48 h in the presence of lansoprazole (P-ATPase inhibitor), bafilomycin A1 (V-ATPase inhibitor), or the control solvent dimethylsulfoxide. The MPs were then examined for cytokine expression by quantitative real-time polymerase chain reaction (PCR), and culture supernatants were examined for cytokine production with a multiplex assay in a suspension array system. The possible existence of P-ATPase mRNA in MPs was explored using reverse-transcriptase PCR. P-ATPase mRNA was not detected in MP cells. However, all examined proinflammatory cytokines decreased significantly in their mRNA and protein expression in the lansoprazole-treated group. Conversely, bafilomycin A1 increased the levels of these cytokines. Lansoprazole might be useful for the treatment of inflammatory bowel diseases (IBDs), including Crohn’s disease, as it suppresses the production of relevant MP proinflammatory cytokines. However, because P-ATPase was not detected in MPs, the mechanism is unclear and remains to be studied further in an IBD animal model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Mahida YR (2000) The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 6:21–33

    Article  PubMed  CAS  Google Scholar 

  2. Sawa Y, Oshitani N, Adachi K et al (2003) Comprehensive analysis of intestinal cytokine messenger RNA profile by real-time quantitative polymerase chain reaction in patients with inflammatory bowel disease. Int J Mol Med 11:175–179

    PubMed  CAS  Google Scholar 

  3. Ogata H, Hibi T (2003) Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr Pharm Des 9:1107–1113

    Article  PubMed  CAS  Google Scholar 

  4. Hibi T, Inoue N, Ogata H et al (2003) Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease. J Gastroenterol 38:36–42

    Article  PubMed  CAS  Google Scholar 

  5. Baert F, Noman M, Vermeire S et al (2003) Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease. N Engl J Med 348:601–608

    Article  PubMed  CAS  Google Scholar 

  6. Ito H (2005) Treatment of Crohn’s disease with anti-IL-6 receptor antibody. J Gastroenterol 40:32–34

    Article  PubMed  CAS  Google Scholar 

  7. Ito H, Takazoe M, Fukuda Y et al (2004) A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease. Gastroenterology 126:989–996

    Article  PubMed  CAS  Google Scholar 

  8. Yoshida N, Yoshikawa T, Tanaka Y et al (2000) A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther 14:74–81

    Article  PubMed  CAS  Google Scholar 

  9. Ohara T, Arakawa T (1999) Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells. Dig Dis Sci 44:1710–1715

    Article  PubMed  CAS  Google Scholar 

  10. Bicakci U, Tander B, Ariturk E et al (2005) Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia/reoxygenation induced intestinal injury in newborn rats. Pediatr Surg Int 21:800–805

    Article  PubMed  Google Scholar 

  11. Suzuki M, Mori M, Miura S et al (1996) Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radic Biol Med 21:727–731

    Article  PubMed  CAS  Google Scholar 

  12. Wandall JH (1992) Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245. Gut 33:617–621

    PubMed  CAS  Google Scholar 

  13. Suzuki M, Nakamura M, Mori M et al (1995) Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori. J Clin Gastroenterol 20:93–96

    Article  Google Scholar 

  14. Dickinson JB (1994) Is omeprazole helpful in inflammatory bowel disease? J Clin Gastroenterol 18:317–319

    Article  PubMed  CAS  Google Scholar 

  15. Valori RM, Cockel R (1990) Omeprazole for duodenal ulceration in Crohn’s disease. BMJ 300:438–439

    Article  PubMed  CAS  Google Scholar 

  16. Forgac M (1989) Structure and function of vacuolar class of ATP-driven proton pumps. Physiol Rev 69:765–796

    PubMed  CAS  Google Scholar 

  17. Nelson N (1989) Structure, molecular genetics, and evolution of vacuolar H+-ATPases. J Bioenerg Biomembr 21:553–571

    Article  PubMed  CAS  Google Scholar 

  18. Moriyama Y, Futai M (1990) H(+)-ATPase, a primary pump for accumulation of neurotransmitters, is a major constituent of brain synaptic vesicles. Biochem Biophys Res Commun 173:443–448

    Article  PubMed  CAS  Google Scholar 

  19. Vaananen HK, Karhukorpi EK, Sundquist K et al (1990) Evidence for the presence of a proton pump of the vacuolar (H+)-ATPase type in the ruffled borders of osteoclasts. J Cell Biol 111:1305–1311

    Article  PubMed  CAS  Google Scholar 

  20. Martinez-Zaguilan R, Lynch RM, Martinez GM et al (1993) Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol 265:1015–1029

    Google Scholar 

  21. Yoshimura K, Kametani F, Shimoda Y et al (2001) Antigens of monoclonal antibody NB3C4 are novel markers for oligodendrocytes. Neuroreport 12:417–421

    Article  PubMed  CAS  Google Scholar 

  22. Bunge RP, Wood P (1973) Studies on the transplantation of spinal cord tissue in the rat. Ι. The development of a culture system for hemisections of embryonic spinal cord. Brain Res 57:261–276

    Article  PubMed  CAS  Google Scholar 

  23. Carmosino M, Mazzone A, Laforenza U et al (2005) Altered expression of aquaporin 4 and H(+)/K(+)-ATPase in the stomachs of peptide YY(PYY)transgenic mice. Biol Cell 97:735–742

    Article  PubMed  CAS  Google Scholar 

  24. Yamamoto M, Yoshizaki K, Kishimoto T et al (2000) IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol 164:4878–4882

    PubMed  CAS  Google Scholar 

  25. Ito H, Hirotani T, Yamamoto M et al (2002) Anti-IL-6 receptor monoclonal antibody inhibits leukocyte recruitment and promotes T-cell apoptosis in a murine model of Crohn’s disease. J Gastroenterol 37:56–61

    Article  PubMed  CAS  Google Scholar 

  26. Nakamura M, Asada M, Atsuda K et al (2005) Lansoprazole binding to the neutrophils in dextran sulfate sodium-induced rat colitis. Inflammopharmacology 13:303–315

    Article  PubMed  CAS  Google Scholar 

  27. Kuroda M, Yoshida N, Ichikawa H et al (2006) Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Int J Mol Med 17:89–93

    PubMed  CAS  Google Scholar 

  28. Ohta T, Numata M, Yagishita H et al (1996) Expression of 16 kDa proteolipid of vacuolar-type H(+)- ATPase in human pancreatic cancer. Br J Cancer 73:1511–1517

    PubMed  CAS  Google Scholar 

  29. Bidani A, Reisner BS, Haque AK et al (2000) Bactericidal activity of alveolar macrophages is suppressed by V-ATPase inhibition. Lung 178:91–104

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are thankful to Mrs. Kayoko Tanaka, Division of Morphological Science, Saitama Medical School for her collaboration in this research. The experiments reported in this article were carried out after the approval of The Animal Research Committee of Saitama Medical School (approval no. 000368) and are in compliance with the current laws of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akinari Hinoki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hinoki, A., Yoshimura, K., Fujita, K. et al. Suppression of proinflammatory cytokine production in macrophages by lansoprazole. Pediatr Surg Int 22, 915–923 (2006). https://doi.org/10.1007/s00383-006-1767-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-006-1767-8

Keywords

Navigation